Tina Saeidi , Warren D. Foltz , W. Jeffrey Zabel , Michael.J. Daly , I. Alex Vitkin , Margarete K. Akens , Lothar Lilge
{"title":"Are blood flow and blood volume predictors of localized photosensitizer accumulation in the brain?","authors":"Tina Saeidi , Warren D. Foltz , W. Jeffrey Zabel , Michael.J. Daly , I. Alex Vitkin , Margarete K. Akens , Lothar Lilge","doi":"10.1016/j.pdpdt.2025.104689","DOIUrl":null,"url":null,"abstract":"<div><h3>Significance</h3><div>The efficacy of photodynamic therapy (PDT) can be impacted by heterogeneous Photosensitizer (PS) accumulation. Our previous study indicated that neglecting spatial variations in photosensitizer (PS) accumulation during treatment planning can result in morbidity and treatment failure. Knowledge and incorporation of the PS distribution at the 1 mm³ scale in the treatment planning process can compensate for heterogeneous PS efficacy losses. Effects of vascular perfusion parameters in the brain and local PS concentration are investigated.</div></div><div><h3>Aim</h3><div>Correlations between MRI-derived blood flow (BF), blood volume (BV), mean transit time (MTT), and quantitative Spatial Frequency Domain imaging (qSFDI) of the photosensitizer concentration [PS] in the tumour rim, core, and normal brain are investigated.</div></div><div><h3>Method</h3><div><em>In-vivo</em> MRI with continuous arterial spin labeling (CASL) and intravoxel incoherent motion (IVIM) provided BF, BV, and MTT in a rat glioma model for the tumour regions, normal brain, and spatially resolved within 1.5 mm of the tumour rim. Two photosensitizers were used: a small-molecule agent (Ce6) and a nanoparticle-based formulation (Porphysome). qSFDI provided spatially resolved [PS], which was co-registered with the MRI data to enable evaluation of the perfusion and [PS] correlation strength.</div></div><div><h3>Results</h3><div>The imaging techniques showed elevated BF and [PS] in the tumour rim and reduced BF and [PS] in the tumour core, but BV did not differ between the core and rim. No strong correlations between any perfusion parameter and <em>ex-vivo</em> [PS] were observed. A strong positive [PS] gradient was noted from the tumour’s outer rim towards its centre. This spatial uptake trend was observed for both photosensitizers, with Porphysome showing a steeper gradient and higher overall accumulation.</div></div><div><h3>Conclusion</h3><div>These findings highlight that MR perfusion metrics alone are insufficient to predict spatial [PS] in solid brain tumours for PDT pre-treatment planning.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"54 ","pages":"Article 104689"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photodiagnosis and Photodynamic Therapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1572100025002212","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Significance
The efficacy of photodynamic therapy (PDT) can be impacted by heterogeneous Photosensitizer (PS) accumulation. Our previous study indicated that neglecting spatial variations in photosensitizer (PS) accumulation during treatment planning can result in morbidity and treatment failure. Knowledge and incorporation of the PS distribution at the 1 mm³ scale in the treatment planning process can compensate for heterogeneous PS efficacy losses. Effects of vascular perfusion parameters in the brain and local PS concentration are investigated.
Aim
Correlations between MRI-derived blood flow (BF), blood volume (BV), mean transit time (MTT), and quantitative Spatial Frequency Domain imaging (qSFDI) of the photosensitizer concentration [PS] in the tumour rim, core, and normal brain are investigated.
Method
In-vivo MRI with continuous arterial spin labeling (CASL) and intravoxel incoherent motion (IVIM) provided BF, BV, and MTT in a rat glioma model for the tumour regions, normal brain, and spatially resolved within 1.5 mm of the tumour rim. Two photosensitizers were used: a small-molecule agent (Ce6) and a nanoparticle-based formulation (Porphysome). qSFDI provided spatially resolved [PS], which was co-registered with the MRI data to enable evaluation of the perfusion and [PS] correlation strength.
Results
The imaging techniques showed elevated BF and [PS] in the tumour rim and reduced BF and [PS] in the tumour core, but BV did not differ between the core and rim. No strong correlations between any perfusion parameter and ex-vivo [PS] were observed. A strong positive [PS] gradient was noted from the tumour’s outer rim towards its centre. This spatial uptake trend was observed for both photosensitizers, with Porphysome showing a steeper gradient and higher overall accumulation.
Conclusion
These findings highlight that MR perfusion metrics alone are insufficient to predict spatial [PS] in solid brain tumours for PDT pre-treatment planning.
期刊介绍:
Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.